Lidia Maria Veras Rocha De Moura, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 21 | 2024 | 3327 | 4.000 |
Why?
|
Anticonvulsants | 6 | 2021 | 1923 | 1.680 |
Why?
|
Aedes | 2 | 2023 | 101 | 1.620 |
Why?
|
Neurology | 6 | 2024 | 786 | 1.560 |
Why?
|
Insecticides | 2 | 2023 | 200 | 1.530 |
Why?
|
Seizures | 14 | 2024 | 2998 | 1.440 |
Why?
|
Quality of Health Care | 7 | 2024 | 4310 | 1.210 |
Why?
|
International Classification of Diseases | 4 | 2022 | 937 | 1.190 |
Why?
|
Medicare | 9 | 2024 | 6809 | 0.870 |
Why?
|
Medical Records | 3 | 2017 | 1410 | 0.810 |
Why?
|
Dementia | 5 | 2024 | 2740 | 0.800 |
Why?
|
Electronic Health Records | 8 | 2024 | 4887 | 0.800 |
Why?
|
Benzodiazepines | 2 | 2024 | 1138 | 0.740 |
Why?
|
Brain Ischemia | 3 | 2022 | 3007 | 0.690 |
Why?
|
Stroke | 5 | 2022 | 9755 | 0.680 |
Why?
|
Natural Language Processing | 3 | 2024 | 1203 | 0.620 |
Why?
|
Social Environment | 1 | 2023 | 1012 | 0.590 |
Why?
|
Quality Improvement | 6 | 2022 | 3857 | 0.560 |
Why?
|
Epilepsy, Temporal Lobe | 2 | 2022 | 390 | 0.560 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2016 | 46 | 0.540 |
Why?
|
Algorithms | 7 | 2024 | 14164 | 0.490 |
Why?
|
Databases, Factual | 3 | 2020 | 8080 | 0.460 |
Why?
|
Documentation | 1 | 2020 | 917 | 0.440 |
Why?
|
Delirium | 2 | 2022 | 1697 | 0.430 |
Why?
|
Electroencephalography | 6 | 2023 | 6314 | 0.370 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2008 | 0.370 |
Why?
|
Status Epilepticus | 1 | 2016 | 463 | 0.360 |
Why?
|
Medicaid | 1 | 2024 | 2840 | 0.360 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 939 | 0.350 |
Why?
|
Health Expenditures | 2 | 2022 | 2389 | 0.350 |
Why?
|
Psychometrics | 1 | 2019 | 3063 | 0.340 |
Why?
|
Cerebral Hemorrhage | 1 | 2021 | 2655 | 0.340 |
Why?
|
Brain Waves | 1 | 2014 | 417 | 0.340 |
Why?
|
Perception | 1 | 2016 | 1209 | 0.330 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.330 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3081 | 0.320 |
Why?
|
Aged | 25 | 2024 | 171504 | 0.310 |
Why?
|
Humans | 49 | 2024 | 768166 | 0.280 |
Why?
|
Counseling | 1 | 2015 | 1554 | 0.270 |
Why?
|
Quality of Life | 5 | 2023 | 13490 | 0.270 |
Why?
|
Cost of Illness | 1 | 2016 | 1951 | 0.270 |
Why?
|
Health Personnel | 1 | 2020 | 3385 | 0.270 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1662 | 0.260 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1668 | 0.250 |
Why?
|
Emergency Service, Hospital | 2 | 2024 | 7951 | 0.250 |
Why?
|
Middle Aged | 22 | 2024 | 223492 | 0.240 |
Why?
|
Female | 28 | 2024 | 397192 | 0.240 |
Why?
|
Guideline Adherence | 1 | 2015 | 2235 | 0.240 |
Why?
|
Adult | 22 | 2024 | 223646 | 0.240 |
Why?
|
Alprazolam | 1 | 2024 | 103 | 0.240 |
Why?
|
Male | 25 | 2024 | 364719 | 0.230 |
Why?
|
Aged, 80 and over | 10 | 2024 | 59629 | 0.230 |
Why?
|
Lorazepam | 1 | 2024 | 155 | 0.220 |
Why?
|
Young Adult | 11 | 2024 | 60066 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3109 | 0.210 |
Why?
|
United States | 10 | 2024 | 73039 | 0.210 |
Why?
|
Physician-Patient Relations | 1 | 2016 | 3269 | 0.210 |
Why?
|
Mosquito Control | 1 | 2023 | 110 | 0.210 |
Why?
|
Socioeconomic Factors | 3 | 2023 | 7852 | 0.200 |
Why?
|
Larva | 1 | 2023 | 515 | 0.190 |
Why?
|
Oligochaeta | 1 | 2021 | 10 | 0.190 |
Why?
|
Soil Pollutants | 1 | 2021 | 78 | 0.180 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.180 |
Why?
|
Retrospective Studies | 12 | 2022 | 81762 | 0.170 |
Why?
|
Cohort Studies | 6 | 2023 | 41754 | 0.160 |
Why?
|
Brazil | 1 | 2023 | 1250 | 0.160 |
Why?
|
Reimbursement Mechanisms | 1 | 2024 | 670 | 0.150 |
Why?
|
Mass Screening | 1 | 2014 | 5458 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7454 | 0.150 |
Why?
|
Reference Standards | 1 | 2021 | 1014 | 0.140 |
Why?
|
Medicare Part C | 1 | 2022 | 332 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26379 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2234 | 0.140 |
Why?
|
Cerebrovascular Disorders | 1 | 2023 | 1485 | 0.130 |
Why?
|
Sclerosis | 1 | 2016 | 211 | 0.130 |
Why?
|
Proxy | 1 | 2016 | 150 | 0.120 |
Why?
|
Laser Therapy | 1 | 2022 | 1107 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1474 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2016 | 211 | 0.120 |
Why?
|
Hospitalization | 4 | 2024 | 10840 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1741 | 0.120 |
Why?
|
Automobile Driving | 1 | 2019 | 442 | 0.120 |
Why?
|
Life Expectancy | 1 | 2021 | 1248 | 0.110 |
Why?
|
Communication | 2 | 2020 | 3905 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2016 | 15832 | 0.110 |
Why?
|
Survivors | 1 | 2024 | 2381 | 0.110 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2017 | 359 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2023 | 2118 | 0.100 |
Why?
|
Prevalence | 2 | 2021 | 15869 | 0.100 |
Why?
|
Adolescent | 6 | 2024 | 89169 | 0.100 |
Why?
|
Spectrum Analysis | 1 | 2014 | 449 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1178 | 0.100 |
Why?
|
Pyridines | 1 | 2023 | 2894 | 0.090 |
Why?
|
Alzheimer Disease | 2 | 2022 | 8759 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2023 | 5349 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1835 | 0.080 |
Why?
|
Brain Diseases | 1 | 2017 | 1554 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5536 | 0.070 |
Why?
|
Folic Acid | 1 | 2015 | 1337 | 0.070 |
Why?
|
Medication Adherence | 1 | 2019 | 2187 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5367 | 0.070 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39348 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3740 | 0.070 |
Why?
|
Logistic Models | 1 | 2021 | 13290 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2016 | 5315 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2022 | 65371 | 0.060 |
Why?
|
Self Report | 1 | 2016 | 3773 | 0.060 |
Why?
|
Registries | 2 | 2021 | 8375 | 0.060 |
Why?
|
Critical Care | 1 | 2017 | 2715 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2517 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8509 | 0.060 |
Why?
|
Prospective Studies | 2 | 2019 | 54926 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4091 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20227 | 0.050 |
Why?
|
Animals | 3 | 2023 | 169246 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4206 | 0.050 |
Why?
|
Monitoring, Physiologic | 2 | 2022 | 1798 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4492 | 0.050 |
Why?
|
Ecotoxicology | 1 | 2021 | 8 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2015 | 3301 | 0.050 |
Why?
|
Toxicity Tests | 1 | 2021 | 114 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2973 | 0.050 |
Why?
|
Soil | 1 | 2021 | 120 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18412 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2022 | 599 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15948 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4598 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9263 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5812 | 0.040 |
Why?
|
Reproduction | 1 | 2021 | 646 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1254 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6568 | 0.030 |
Why?
|
Infant | 1 | 2016 | 36535 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3327 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 42669 | 0.030 |
Why?
|
Tunica Intima | 1 | 2015 | 459 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30256 | 0.030 |
Why?
|
Child | 2 | 2021 | 80917 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2017 | 754 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2862 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3785 | 0.020 |
Why?
|
Software | 1 | 2023 | 4478 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2015 | 1895 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3886 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7073 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 1551 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6793 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14729 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 6004 | 0.010 |
Why?
|
Brain Mapping | 1 | 2017 | 6685 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74944 | 0.010 |
Why?
|
Critical Illness | 1 | 2014 | 2756 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13671 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22291 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2022 | 36743 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40218 | 0.010 |
Why?
|